| For: | Wang XW, Tang YX, Li FX, Wang JL, Yao GP, Zeng DT, Tang YL, Chi BT, Su QY, Huang LQ, Qin DY, Chen G, Feng ZB, He RQ. Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(10): 4244-4263 [PMID: 39473957 DOI: 10.4251/wjgo.v16.i10.4244] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i10/4244.htm |
| Number | Citing Articles |
| 1 |
Yu-Run Miao, Xiao-Jun Yang. Hepatocellular carcinoma resistance to tyrosine kinase inhibitors: Current status and perspectives. World Journal of Gastrointestinal Oncology 2025; 17(4): 101528 doi: 10.4251/wjgo.v17.i4.101528
|
